124 related articles for article (PubMed ID: 19303174)
1. Synthesis and biochemical evaluation of a cyclic RGD oxorhenium complex as new ligand of alphaVbeta3 integrin.
Aufort M; Gonera M; Chaignon N; Le Clainche L; Dugave C
Eur J Med Chem; 2009 Sep; 44(9):3394-401. PubMed ID: 19303174
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro screening and in vivo evaluation of cyclic RGD analogs cyclized through oxorhenium and oxotechnetium coordination.
Aufort M; Gonera M; Lelait MA; Czarny B; Le Clainche L; Thaï R; Landra A; Ruinart de Brimont M; Dugave C
Eur J Med Chem; 2011 May; 46(5):1779-88. PubMed ID: 21392860
[TBL] [Abstract][Full Text] [Related]
3. Chelate oxorhenium to assemble new integrin antagonists.
Le Gal J; Gonera M; Lelait MA; Servent D; Dugave C
J Inorg Biochem; 2011 Jun; 105(6):880-6. PubMed ID: 21510913
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and in vitro evaluation of new oxorhenium- and oxotechnetium-CCK4 derivatives as molecular imaging agents for CCK2-receptor targeting.
Dorbes S; Mestre-Voegtlé B; Coulais Y; Picard C; Silvente-Poirot S; Poirot M; Benoist E
Eur J Med Chem; 2010 Feb; 45(2):423-9. PubMed ID: 19853977
[TBL] [Abstract][Full Text] [Related]
5. Oxorhenium-mediated assembly of noncyclic selective integrin antagonists: a combinatorial approach.
Aufort M; Gonera M; Le Gal J; Czarny B; Le Clainche L; Thai R; Dugave C
Chembiochem; 2011 Mar; 12(4):583-92. PubMed ID: 21305682
[TBL] [Abstract][Full Text] [Related]
6. Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting.
Manzoni L; Belvisi L; Arosio D; Civera M; Pilkington-Miksa M; Potenza D; Caprini A; Araldi EM; Monferini E; Mancino M; Podestà F; Scolastico C
ChemMedChem; 2009 Apr; 4(4):615-32. PubMed ID: 19212960
[TBL] [Abstract][Full Text] [Related]
7. Cyclic and acyclic oxorhenium(V)-peptide conjugates as new ligands of the human cyclophilin hCyp-18.
Clavaud C; Heckenroth M; Stricane C; Ménez A; Dugave C
Bioconjug Chem; 2006; 17(3):807-14. PubMed ID: 16704221
[TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1.
Conradi J; Huber S; Gaus K; Mertink F; Royo Gracia S; Strijowski U; Backert S; Sewald N
Amino Acids; 2012 Jul; 43(1):219-32. PubMed ID: 21915696
[TBL] [Abstract][Full Text] [Related]
9. Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding.
Kubas H; Schäfer M; Bauder-Wüst U; Eder M; Oltmanns D; Haberkorn U; Mier W; Eisenhut M
Nucl Med Biol; 2010 Nov; 37(8):885-91. PubMed ID: 21055618
[TBL] [Abstract][Full Text] [Related]
10. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
Arosio D; Manzoni L; Araldi EM; Caprini A; Monferini E; Scolastico C
Bioconjug Chem; 2009 Aug; 20(8):1611-7. PubMed ID: 21141806
[TBL] [Abstract][Full Text] [Related]
11. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies.
Guzzetti I; Civera M; Vasile F; Araldi EM; Belvisi L; Gennari C; Potenza D; Fanelli R; Piarulli U
Org Biomol Chem; 2013 Jun; 11(23):3886-93. PubMed ID: 23657523
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of Tc-99m labeled glucosamino-Asp-cyclic(Arg-Gly-Asp-d-Phe-Lys) as a potential angiogenesis imaging agent.
Lee BC; Sung HJ; Kim JS; Jung KH; Choe YS; Lee KH; Chi DY
Bioorg Med Chem; 2007 Dec; 15(24):7755-64. PubMed ID: 17890093
[TBL] [Abstract][Full Text] [Related]
13. Cyclic DGR-peptidomimetic containing a bicyclic reverse turn inducer as a selective alpha(v)beta (5) integrin ligand.
Trabocchi A; Menchi G; Danieli E; Potenza D; Cini N; Bottoncetti A; Raspanti S; Pupi A; Guarna A
Amino Acids; 2010 Jan; 38(1):329-37. PubMed ID: 19267182
[TBL] [Abstract][Full Text] [Related]
14. Discrete functional motifs reside within the cytoplasmic tail of alphaV integrin subunit.
Haas TA
Thromb Haemost; 2008 Jan; 99(1):96-107. PubMed ID: 18217140
[TBL] [Abstract][Full Text] [Related]
15. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M
Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
[TBL] [Abstract][Full Text] [Related]
16. Preparation and biological characterization of isomeric 188Re(V) oxocomplexes with tetradentate S4 ligands derived from meso-dimercaptosuccinic acid for labeling of biomolecules.
Seifert S; Heinrich T; Jentschel C; Smuda C; Bergmann R; Pietzsch HJ
Bioconjug Chem; 2006; 17(6):1601-6. PubMed ID: 17105241
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome.
Waldeck J; Häger F; Höltke C; Lanckohr C; von Wallbrunn A; Torsello G; Heindel W; Theilmeier G; Schäfers M; Bremer C
J Nucl Med; 2008 Nov; 49(11):1845-51. PubMed ID: 18927332
[TBL] [Abstract][Full Text] [Related]
18. Multiple N-methylation by a designed approach enhances receptor selectivity.
Chatterjee J; Ovadia O; Zahn G; Marinelli L; Hoffman A; Gilon C; Kessler H
J Med Chem; 2007 Nov; 50(24):5878-81. PubMed ID: 17973471
[TBL] [Abstract][Full Text] [Related]
19. Stereodivergent synthesis of 5-aminopipecolic acids and application in the preparation of a cyclic RGD peptidomimetic as a nanomolar α
Sernissi L; Ricci L; Scarpi D; Bianchini F; Arosio D; Contini A; Occhiato EG
Org Biomol Chem; 2018 May; 16(18):3402-3414. PubMed ID: 29675532
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting α(v)β(3)/α(v)β(5) integrins and IAP proteins.
Mingozzi M; Manzoni L; Arosio D; Dal Corso A; Manzotti M; Innamorati F; Pignataro L; Lecis D; Delia D; Seneci P; Gennari C
Org Biomol Chem; 2014 May; 12(20):3288-302. PubMed ID: 24737345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
